Form 4: CorMedix COO Sells Shares in Routine Transaction

CorMedix Inc.'s Chief Operating Officer, Elizabeth Hurlburt, reported the disposition of 10,895 shares of common stock at $12.16 per share.

Summary

• Elizabeth Hurlburt, Chief Operating Officer of CorMedix Inc., reported a transaction involving company common stock.
• On January 2, 2026, Hurlburt disposed of 10,895 shares of CorMedix common stock.
• The shares were disposed of at a price of $12.16 per share.
• Following this transaction, Hurlburt directly beneficially owns 166,095 shares of CorMedix common stock.
• The transaction code 'F' typically indicates a disposition to cover tax obligations related to the vesting of equity awards.

Sentiment

Score: 5

Explanation: The transaction is a routine disposition of shares by an officer, likely for tax purposes related to equity compensation, and does not indicate a significant positive or negative sentiment regarding the company's prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• The disposition of shares by a Chief Operating Officer is a routine event, typically for tax purposes, and is unlikely to have a material impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Recommendation

The reported transaction is a routine disposition of shares by an officer, likely to cover tax obligations associated with equity compensation. Such transactions are common and generally do not reflect a change in the officer's outlook on the company's fundamentals or future prospects. Therefore, it does not provide a basis for altering an existing investment thesis.

Keywords

CorMedix Inc., CRMD, Insider Trading, Form 4, Elizabeth Hurlburt, Stock Sale, Officer Transaction, Common Stock